Clinical and computed tomography features (CT) of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutation and anaplastic lymphoma kinase (ALK) status
R. Castañon Perez (Burgos, Spain), G. Gutiérrez Herrero (Burgos, Spain), H. Álvarez Martínez (Burgos, Spain), P. Lozano Cuesta (Burgos, Spain), O. Sánchez Martin (Burgos, Spain), M. Arias Fuente (Burgos, Spain), L. Castallanos Romero (Burgos, Spain), L. Rodríguez Pascual (Burgos, Spain)
Source: Virtual Congress 2020 – Real-world data and registries of thoracic oncology
Session: Real-world data and registries of thoracic oncology
Session type: E-poster session
Number: 1696
Disease area: Thoracic oncology
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Castañon Perez (Burgos, Spain), G. Gutiérrez Herrero (Burgos, Spain), H. Álvarez Martínez (Burgos, Spain), P. Lozano Cuesta (Burgos, Spain), O. Sánchez Martin (Burgos, Spain), M. Arias Fuente (Burgos, Spain), L. Castallanos Romero (Burgos, Spain), L. Rodríguez Pascual (Burgos, Spain). Clinical and computed tomography features (CT) of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutation and anaplastic lymphoma kinase (ALK) status. 1696
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: